Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing in the General Population in Community Settings
Respiratory infections are very common, especially during winter, and are often caused by viruses such as influenza, SARS-CoV-2 or respiratory syncytial virus (RSV). These illnesses are generally mild, but their symptoms do not always allow a clear distinction to be made between a viral infection and a bacterial infection. In the absence of a precise diagnosis, antibiotics may be prescribed when they are not necessary in many cases. However, the excessive use of antibiotics contributes to the development of bacterial resistance, which is a major public health issue. The aim of this study is to better understand whether the use of a rapid test (called TROD), which can quickly identify certain respiratory viruses, can help doctors reduce unnecessary antibiotic prescriptions for these infections. The test will be performed using a swab gently inserted into the nose.
• Age ≥ 1 year
• Presenting with:
‣ Either fever (temperature \> 38°C measured by patient or physician) within the past 72 hours, and one of the following symptom combinations:
• Rhinorrhea (white, yellow, or green discharge) and/or nasal obstruction, and cough
∙ Body aches, cough, and fatigue
∙ Odynophagia and negative strepto-test
∙ Cough
∙ Otalgia
⁃ Or suspicion of lower respiratory tract infection: signs of infection (respiratory rate \> 20/min, heart rate \> 100/min, fatigue, Body aches, chills, or fever), associated with pulmonary localization signs \[cough, sputum, chest pain, auscultatory abnormality (rhonchi, crackles, or wheezing)\]
• Affiliation with the national health insurance system
• Informed consent obtained from the adult participant, or from the person(s) with parental authority for a minor participant